U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07005947) titled 'Long COVID Cutaneous Signatures: An ARPA Funded Research Project' on June 03.
Brief Summary: This is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID neurocutaneous biosignatures with those of other disorders affecting the sensory and autonomic nervous system.
Study Start Date: Nov. 30, 2023
Study Type: OBSERVATIONAL
Condition:
Long COVID
Acute COVID-19
Postural Orthostatic Tachycardia Syndrome (POTS)
Diabetic Neuropathy
Recruitment Status: RECRUITING
Sponsor: CND Life Sciences
Disclaimer: Curated by HT Syndication....